All Type of News
Government completed reimbursement negotiation of 2015
Government completed reimbursement negotiation of 2015. The chief beneficiary of reimbursement negotiation is KPA, which recorded rise rate of 3.2%, which is 0.4% higher than the rise rate in 2014.
KMA signed a contr...
The implementation of 'Illegal kickback Two-strike out system' in July has caused alarm among pharmaceutical community
The implementation of 'Illegal kickback Two-strike out system' in July has caused alarm among pharmaceutical community.
Each pharmaceutical company is concerning that "Our company may fail if we don't obey the law." ...
Multinational pharmaceutical companies seem to avoid entering into domestic market
Recently, according to industry official related to clinical trial, it was analyzed that domestic clinical trial has joined the ranks of advanced countries, but clinical trial may not activated as it used to be. The r...
Chong Kun Dang embarked on the patent challenge of Celebrex
Chong Kun Dang embarked on the patent challenge of Celebrex (Pfizer Korea) which is an absolute leader in the field analgesic and anti-inflammatory.
Celebrex is one of the cox-2 inhibitors for pain relief recording s...
Partial insurance benefit restriction of Stillen was suspended until June 20
Partial insurance benefit restriction of Stillen was suspended until June 20. Thus, patients can receive insurance benefit of Stillen when used for the purpose of preventing gastritis which is caused by NSAIDs.
Seoul...
Doctors are requesting modification of current Diagnosis Related Group Payment System
Diagnosis Related Group Payment System is a system in which patients should pay fixed amount of money determined by disease.
The common problem of Diagnosis Related Group Payment System includes ▲low insurance reimbu...
The prescription cost of top multinational pharmaceutical companies shows increasing trend
According to the analysis of prescription cost of top 18 multinational pharmaceutical companies, their prescription cost from January to April 2014 increased by 4.5%, from 774.2 billion won in the previous year to 808...
The top domestic pharmaceutical companies recorded average expected revenue growth of about 8%
On May 29, according to the analysis of profit figure of the top five pharmaceutical companies in the second quarter, it was analyzed that their average expected revenue growth is about 8%.
Yuhan Corporation is expec...
Pfizer Korea appealed administrative judgment, for the purpose of returning the price of neuropathic pain treatment ‘Lyrica’ to the original state
Pfizer Korea appealed administrative judgment to Anti-Corruption and Civil Rights Commission for the purpose of returning the price of neuropathic pain treatment ‘Lyrica’ (pregabalin) to the original state.
Pfizer Ko...
Health Insurance Corporation lost 6 cases of lawsuit for returning pharmaceutical fee for synthesizing drug substance against pharmaceutical companies
Health Insurance Corporation lost 6 cases of lawsuit for returning pharmaceutical fee for synthesizing drug substance against pharmaceutical companies.
The lawsuit for synthesizing drug substance originated from the ...
